Zacks Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-909
| Closed | -$223K | – | 504 |
|
2020
Q4 | $223K | Sell |
909
-67
| -7% | -$16.4K | ﹤0.01% | 489 |
|
2020
Q3 | $277K | Sell |
976
-25,410
| -96% | -$7.21M | 0.01% | 462 |
|
2020
Q2 | $7.06M | Sell |
26,386
-18,880
| -42% | -$5.05M | 0.16% | 124 |
|
2020
Q1 | $14.3M | Buy |
45,266
+217
| +0.5% | +$68.7K | 0.35% | 79 |
|
2019
Q4 | $13.4M | Sell |
45,049
-405
| -0.9% | -$120K | 0.25% | 92 |
|
2019
Q3 | $10.6M | Buy |
45,454
+61
| +0.1% | +$14.2K | 0.21% | 104 |
|
2019
Q2 | $10.6M | Sell |
45,393
-23
| -0.1% | -$5.38K | 0.22% | 98 |
|
2019
Q1 | $10.7M | Buy |
45,416
+566
| +1% | +$134K | 0.23% | 98 |
|
2018
Q4 | $13.5M | Sell |
44,850
-1,267
| -3% | -$381K | 0.33% | 77 |
|
2018
Q3 | $16.3M | Buy |
46,117
+8,310
| +22% | +$2.94M | 0.34% | 78 |
|
2018
Q2 | $11M | Sell |
37,807
-62
| -0.2% | -$18K | 0.24% | 96 |
|
2018
Q1 | $10.4M | Buy |
37,869
+232
| +0.6% | +$63.5K | 0.23% | 98 |
|
2017
Q4 | $12M | Sell |
37,637
-137
| -0.4% | -$43.6K | 0.26% | 90 |
|
2017
Q3 | $11.8M | Buy |
37,774
+16,193
| +75% | +$5.07M | 0.28% | 93 |
|
2017
Q2 | $5.86M | Sell |
21,581
-101
| -0.5% | -$27.4K | 0.15% | 131 |
|
2017
Q1 | $5.93M | Buy |
+21,682
| New | +$5.93M | 0.15% | 127 |
|
2015
Q3 | – | Sell |
-1,124
| Closed | -$454K | – | 589 |
|
2015
Q2 | $454K | Buy |
+1,124
| New | +$454K | 0.01% | 453 |
|
2015
Q1 | – | Sell |
-1,479
| Closed | -$502K | – | 628 |
|
2014
Q4 | $502K | Buy |
+1,479
| New | +$502K | 0.02% | 410 |
|
2014
Q2 | – | Sell |
-1,390
| Closed | -$425K | – | 659 |
|
2014
Q1 | $425K | Buy |
+1,390
| New | +$425K | 0.02% | 465 |
|
2013
Q4 | – | Sell |
-6,007
| Closed | -$1.45M | – | 669 |
|
2013
Q3 | $1.45M | Sell |
6,007
-11
| -0.2% | -$2.65K | 0.06% | 191 |
|
2013
Q2 | $1.3M | Buy |
+6,018
| New | +$1.3M | 0.06% | 193 |
|